Advanced

Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.

Edvinsson, Lars LU ; Edvinsson, M L and Angus Deveber, G (2003) In International Angiology 22(2). p.141-147
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
International Angiology
volume
22
issue
2
pages
141 - 147
publisher
Minerva Medica
external identifiers
  • wos:000184273300005
  • pmid:12865879
ISSN
1827-1839
language
English
LU publication?
yes
id
8f6e45bf-366f-48de-929e-a8be29349a45 (old id 116740)
alternative location
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=12865879&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
date added to LUP
2007-06-28 16:15:08
date last changed
2016-04-15 19:45:40
@article{8f6e45bf-366f-48de-929e-a8be29349a45,
  author       = {Edvinsson, Lars and Edvinsson, M L and Angus Deveber, G},
  issn         = {1827-1839},
  language     = {eng},
  number       = {2},
  pages        = {141--147},
  publisher    = {Minerva Medica},
  series       = {International Angiology},
  title        = {Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.},
  volume       = {22},
  year         = {2003},
}